| Page 2065 | Kisaco Research
 

Samer Al-Murrani

Senior Advisor
Wombat Capital

Samer Al-Murrani

Senior Advisor
Wombat Capital

Samer Al-Murrani

Senior Advisor
Wombat Capital
 

Marie-Paul Lachaud

Referent Animal Health R&D
One Health Pharma

Marie-Paul Lachaud, DVM is Head of Program Management Europe at Aratana Therapeutics. Her responsibilities include coordinating the process leading to regulatory approval by the European Medicines Agency for Aratana’s products targeted at unmet medical needs in cats and dogs.

Prior to joining Aratana, Dr. Lachaud served the veterinary pharmaceutical industry as an experienced consultant, with a specific focus on international drug clinical development. 

Marie-Paul Lachaud

Referent Animal Health R&D
One Health Pharma

Marie-Paul Lachaud

Referent Animal Health R&D
One Health Pharma

Marie-Paul Lachaud, DVM is Head of Program Management Europe at Aratana Therapeutics. Her responsibilities include coordinating the process leading to regulatory approval by the European Medicines Agency for Aratana’s products targeted at unmet medical needs in cats and dogs.

Prior to joining Aratana, Dr. Lachaud served the veterinary pharmaceutical industry as an experienced consultant, with a specific focus on international drug clinical development. 

From 2000 to 2008, Dr. Lachaud was the European animal health director at ICON Clinical Research in Paris, France. In 1990, she co-founded PROTOCOLE, the first European veterinary consultancy and contract research organization focused on drug clinical development and regulatory affairs, which was acquired by ICON in 2000. 

Dr. Lachaud has been involved in transitioning human drugs to meet unmet needs in veterinary medicine for years. Her work has resulted in significant animal health product approvals in Europe and the United-States for companion animals in a number of innovative therapeutic areas, including reproduction, chronic heart failure, chronic kidney disease, pain management, oncology and neurobehavioral disorders. 

She received her veterinary degree from Alfort National Veterinary School in Paris and her doctorate in veterinary medicine from the University of Paris, France.

 

CEVA Animal Health Chairman & CEO Marc Prikazsky on Doing Business in China
 

Randolph Seidler

VP, Global Head of Business Development Animal
Boehringer Ingelheim

Randolph Seidler

VP, Global Head of Business Development Animal
Boehringer Ingelheim

Randolph Seidler

VP, Global Head of Business Development Animal
Boehringer Ingelheim
 

Mark Engel

CEO
Phagelux

Mark Engel

CEO
Phagelux

Mark Engel

CEO
Phagelux
 

Candy Cheng

Project Leader
MelchersRaffel LTD

Candy Cheng

Project Leader
MelchersRaffel LTD

Candy Cheng

Project Leader
MelchersRaffel LTD
 
RPA & Cognitive Congress Dallas
17-18 Jan 2018
Dallas, TX, USA
RPA & Cognitive Congress Dallas is assembling leading service delivery and automation professionals for frank and pragmatic discussion about RPA, the benefits and opportunities of this technology, and the real-world challenges they’re facing in implementation.